Hitting Back at Lymphoma: How Do Modern Diagnostics Identify High‐risk Diffuse Large B‐cell Lymphoma Subsets and Alter Treatment?

Cancer - United States
doi 10.1002/cncr.32145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Diffuse Large B-Cell Lymphoma

2020English

Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study

Blood Cancer Journal
OncologyHematology
2016English

Vitreoretinal Lymphoma Followed by Systemic Diffuse Large B Cell Lymphoma

Journal of Ophthalmic Inflammation and Infection
OphthalmologyInfectious Diseases
2019English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Distinction Between "High Grade MALT" and Diffuse Large B Cell Lymphoma

Gut
Gastroenterology
2002English

The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Sao Paulo Medical Journal
Medicine
2010English

Diffuse Large B-Cell Lymphoma With Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies

American Journal of Hematology
Hematology
2017English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy